Abstract: The invention relates to a device assembly and methods useful for producing molded silicone rubber products from liquid silicone rubber compositions (“LSR”) via injection molding. The methods provide a flexible process to produce faster cured silicone rubber products from LSR and allow for use of low curing temperature in the molding cavities without drastically lowering cure speed of the LSR and the physical properties of the produced molded silicone rubber material, therefore allowing liquid silicone rubber overmolding on or over heat sensitive substrates. The device assembly of the invention allows a faster cycle and the use of precise dosing and mixing units thus creating a flexible process to produce cured silicone rubber products faster from liquid silicone rubber (LSR).

Abstract: The invention relates to a device assembly and methods useful for producing molded silicone rubber products from liquid silicone rubber compositions (“LSR”) via injection molding. The methods provide a flexible process to produce faster cured silicone rubber products from LSR and allow for use of low curing temperature in the molding cavities without drastically lowering cure speed of the LSR and the physical properties of the produced molded silicone rubber material, therefore allowing liquid silicone rubber overmolding on or over heat sensitive substrates. The device assembly of the invention allows a faster cycle and the use of precise dosing and mixing units thus creating a flexible process to produce cured silicone rubber products faster from liquid silicone rubber (LSR).

Abstract: The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.

Abstract: The present invention is directed to compounds of formula (i), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.

Abstract: The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.

Abstract: A technique to effect secure communications with a server application, such as server applications that are accessible on the Internet. In one embodiment, a client connection is detected at a first port. The client is provided with a decoy port number. A server provides services to the client on a second port that is mapped to the decoy port number.

Abstract: The disclosed embodiments relate to a system for operating circular files. The system comprises a program designed to write data to a flat file, a pipe having a name corresponding to the flat file and a process that receives the data from the pipe and directs the data to a circular file. The operation of the circular file is transparent to the program.